4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-045422
President and CEO sold 18,333 shares at an average $77.25 ($1,416,300)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-07-01 | Sale | −3,030 | $76.38 | $231,428 | 2,207,712 | I: show line 1 in the form |
| Watts Ryan J. President and CEO | 2021-07-01 | Sale | −12,844 | $77.35 | $993,471 | 2,194,868 | I: show line 2 in the form |
| Watts Ryan J. President and CEO | 2021-07-01 | Sale | −2,459 | $77.84 | $191,401 | 2,192,409 | I: show line 3 in the form |
| Open-market sales · 18,333 sh · avg $77.25 · $1,416,300 | |||||||
Loading xslF345X03/doc4.xml…